1887

oa SA Pharmaceutical Journal - Boniva® : the new quarterly intravenous osteoporosis treatment : drug info - new product focus

 

Abstract

A Boniva® 3 mg/3 ml injection contains the bisphosphonate, ibandronate, and is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.

Loading

Article metrics loading...

/content/mp_sapj/81/9/EJC163773
2014-10-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error